Font Size: a A A
Keyword [disease type]
Result: 181 - 200 | Page: 10 of 10
181. Micronutrient intakes and their associations with markers of inflammation, subclinical atherosclerosis, cardiovascular disease, type II diabetes and metabolic syndrome
182. Muscle biomarkers of type 2 diabetes disease progression in Goto-Kakizaki rats
183. Transition to self-management: Perspectives and experiences of glycogen storage disease type I and type III patients and their parents
184. Hip circumference and chronic disease: Type 2 diabetes, coronary heart disease, hip fractures and functional limitations
185. Characterizing Type I Interferon Mediated Inflammatory Response During Acute and Chronic Infections
186. Glycyl-tRNA synthetase mutations cause Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V: A potentially novel disease mechanism for human peripheral neuropathies
187. Probing the in vivo economy of amyloid beta-protein during the development of Alzheimer's disease-type pathology
188. A role for gangliosides in development of the cerebral cortex and Niemann-Pick disease type C
189. Molecular basis of glycogen storage disease type 1
190. The Role Of Mitochondria In The Amelioration Of Muscular Lipotoxicity By Early Insulin Initiation
191. Erythropoietin Alleviates Hepatic Steatosis And Surpresses Endoplasmic Reticulum Stress
192. The Clinical Characteristics Of Fat Cotent And Fibrosis Of Liver In Various Statuses Of Metabolise
193. Correlation Analysis Between The Level Of Plasma Amino Acids And Type 2 Diabetes Mellitus With Non-alcoholic Fatty Liver Disease
194. Study On The Correlation Between Wnt5a Level And Type 2 Diabetic Kidney Disease
195. Disruption Of Circadian Clocks Promotes Progression Of Alzheimer's Disease In Diabetic Mice
196. Meta Analysis Of The Effect Of Insulin Degludec Versus Insulin Glargine On Cardiovascular And Cerebrovascular Events In Patients With Type 2 Diabetes
197. The Value Of Serum Neutrophil Gelatinase-associated Lipocalin,Cystatin C And Uric Acid In The Early Diagnosis Of Diabetic Kidney Disease
198. Meta-analysis Of The Effect Of SGLT2 Inhibitors On Hepatic Fibrosis In Patients With T2DM Complicated With NAFLD
199. Changes And Clinical Significance Of Soluble ?-klotho In Early Diabetic Kidney Disease
200. The Effects Of Emotional Support And Non-verbal Behaviors On Diagnosis Delivery
  <<First  <Prev  Next>  Last>>  Jump to